$0.93
-0.03 (-3.33%)
Open$0.97
Previous Close$0.96
Day High$0.97
Day Low$0.92
52W High$1.31
52W Low$0.57
Volume—
Avg Volume267.2K
Market Cap75.47M
P/E Ratio—
EPS$-0.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+777.5% upside
Current
$0.93
$0.93
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 33.65M | 21.12M | 9.68M |
| Net Income | -14,059,990 | -7,940,506 | 2.71M |
| Profit Margin | -41.8% | -39.7% | 28.0% |
| EBITDA | -16,824,686 | -10,029,776 | 3.39M |
| Free Cash Flow | — | — | 1.90M |
| Rev Growth | +59.4% | +59.4% | +15.5% |
| Debt/Equity | — | — | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |